Rivaroxaban Use to Prevent Major Clinical Outcomes in Non-Hospitalised Patients With COVID-19
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Disclosure statements are available on the authors' profiles:
eClinicalMedicine
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Rivaroxaban to prevent major clinical outcomes in non-hospitalised patients with COVID-19: the CARE - COALITION VIII randomised clinical trial
EClinicalMedicine 2023 Jun 01;60(2023)102004, Á Avezum, HA Oliveira Junior, PDMM Neves, LBO Alves, AB Cavalcanti, RG Rosa, VC Veiga, LCP Azevedo, SL Zimmermann, OM Silvestre, RC Seabra Prudente, AP Morales Kormann, FR Moreira, I Boszczowski, E de Brito Sobrinho, A da Silva E Souza, R Seligman, B de Souza Paolino, A Razuk, A Diogenes de Magalhaes Feitosa, PL Monteiro Belmonte, P Freitas das Neves Gonçalves, ME Hernandes, AL Fagundes, JM Sarmet Esteves, AP Tognon, J Eikelboom, O Berwanger, RD Lopes, GBF OliveiraFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.